The Patent Finder

Kiniksa Pharmaceuticals, Ltd.

Also on record
Records under this name other than the patents Kiniksa Pharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 7 of 7 · Back to Kiniksa Pharmaceuticals, Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,464,830Treatment of Inflammatory Conditions by Delivery of INTERLEUKIN-1 Receptor Antagonist Fusion Protein
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,844,765Treatment of Inflammatory Conditions by Delivery of INTERLEUKIN-1 Receptor Antagonist Fusion Protein
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,944,666Treatment of Inflammatory Conditions by Delivery of INTERLEUKIN-1 Receptor Antagonist Fusion Protein
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,201,673Treatment of Inflammatory Conditions by Delivery of INTERLEUKIN-1 Receptor Antagonist Fusion Protein
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,026,997Treatment of Inflammatory Conditions by Delivery of INTERLEUKIN-1 Receptor Antagonist Fusion Protein
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,234,294Pharmaceutical composition of a humanized anti-CD40 antibody
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,325,979Treatment of cytokine release syndrome with GM-CSF antagonists
Formerly held
Lapsed on the fee record
Ended May 10, 2026 · USPTO record
Lapsed on the fee recordEnded May 10, 2026USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited